Iridocyclitis: Causes, Symptoms, Risks, and Treatment

What is Iridocyclitis?

Iridocyclitis is an inflammatory condition that affects specific structures of the eye, specifically the iris and the ciliary body. It is the most common form of uveitis and, in the majority of cases, occurs without a clearly identifiable underlying cause (idiopathic). It most commonly affects younger individuals, though it can occur at any age.

Among its known causes are:

• Ocular trauma
• Viral and bacterial infections
• Systemic diseases, especially autoimmune conditions
• Allergic reactions
• Diabetes mellitus

Clinically, iridocyclitis presents with a characteristic set of symptoms:

• Red, irritated eyes and a burning sensation
• Photophobia: painful hypersensitivity to light
• Eye pain and excessive tearing
• Blurred vision

Diagnosis relies on a careful medical history and physical examination, supported by blood tests and specialized ophthalmic investigations. The recognition and management of iridocyclitis requires the expertise of an ophthalmologist (eye specialist).

Iridocyclitis is a serious condition requiring prompt treatment. Without appropriate management, severe complications may arise. These can include permanent structural eye damage and, in the worst cases, blindness.

Treatment is fundamentally etiological, as it focuses on removing or controlling the underlying cause. Anti-inflammatory corticosteroids and mydriatic agents (drugs that dilate the pupil) form the cornerstone of symptomatic management.

---

Anatomy Background

To understand iridocyclitis, it is helpful to review the basic anatomy of the eye. The eye can be conceptualized as composed of three concentric layers:

1. Outer tunic (fibrous layer): consisting of the sclera (the white of the eye) and the cornea (the transparent front surface)
2. Middle tunic (vascular layer): the uvea, the highly vascular intermediate layer that supplies nutrients to the entire eye
3. Inner tunic (nervous layer): the retina, the light-sensitive tissue that converts visual signals into nerve impulses

The Uvea and Its Three Components

The uvea is subdivided into three anatomically distinct structures:

• Iris (anterior)
• Ciliary body (middle)
• Choroid (posterior)

Iridocyclitis corresponds to inflammation of the anterior uvea (iris and ciliary body), and is therefore anatomically synonymous with anterior uveitis.

The Iris

The iris is the colored disc visible in the front of the eye, separating the cornea anteriorly from the lens posteriorly. Its color results from the presence and distribution of melanin pigments in its deeper layer. At the center of the iris is the pupil, an opening that allows light to enter the eye and reach the retina.

The primary function of the iris is to regulate the amount of light entering the eye by adjusting pupil size:

• In bright light: the pupil constricts (miosis) via contraction of the sphincter pupillae muscle
• In dim light: the pupil dilates (mydriasis) via the dilator pupillae muscle, allowing more light to reach the retina

The Ciliary Body

The ciliary body is a ring-shaped structure located behind the iris. It serves two critical functions:

1. Accommodation: the ciliary muscle contracts and relaxes to adjust the lens’s curvature. This allows the eye to focus on objects at varying distances, completing the process in milliseconds
2. Aqueous humor production: the ciliary processes secrete aqueous humor, the clear fluid that fills the anterior chamber and maintains intraocular pressure

---

Causes and Classification

Clinical Course

Iridocyclitis can follow two distinct clinical patterns:

• Acute: sudden onset, typically lasting days to weeks; often painful and symptomatic
• Chronic: inflammation persisting or recurring over a period of at least 3 months; may be more insidious and less symptomatic, making it more difficult to detect early

It may also be:

• Unilateral: affecting one eye only (the most common presentation)
• Bilateral: affecting both eyes simultaneously (less frequent, and more commonly associated with systemic autoimmune disease)

Main Causes

Idiopathic: The most frequent cause, as no identifiable systemic or local disease can be found despite thorough investigation.

Post-surgical uveitis: Inflammatory reaction following intraocular surgery (e.g., cataract surgery).

Ocular trauma: Blunt or penetrating injury to the eye can trigger a local inflammatory cascade.

Diabetes mellitus: Metabolic damage to ocular vasculature can predispose to intraocular inflammation.

Allergic reactions: Hypersensitivity responses can occasionally involve uveal tissue.

Adverse drug reactions: Rare but documented with certain medications.

Autoimmune / systemic diseases: A clinically important group of causes, including:

• Rheumatoid arthritis
• Psoriatic arthritis
• Juvenile idiopathic arthritis, or JIA, is a particularly important association. Children may have minimal symptoms while still developing severe ocular complications
• Systemic lupus erythematosus (SLE)
• Ankylosing spondylitis is strongly associated with the HLA-B27 antigen. One of its most common extra-articular manifestations is anterior uveitis
• Sarcoidosis
• Brucellosis
• Behçet’s disease
• Inflammatory bowel disease (IBD): Crohn’s disease and ulcerative colitis
• Whipple’s disease

Infectious causes:

Viral:

• Herpes simplex virus (HSV)
• Herpes zoster virus (VZV)
• Cytomegalovirus (CMV)
• HIV

Bacterial:

• Staphylococci and streptococci
• Tuberculosis
• Syphilis
• Leprosy

Parasitic:

• Toxoplasmosis
• Toxocariasis

Fungal:

• Candidiasis
• Histoplasmosis

Primary ocular syndromes:

• Fuchs’ heterochromic uveitis (Fuchs’ cyclitis), a chronic and typically low-grade unilateral cyclitis, is often associated with heterochromia, or different iris colors
• Sympathetic ophthalmia, a rare bilateral granulomatous uveitis, occurs after penetrating injury or surgery to one eye
• Glaucoma

Ocular tumors: Primary or metastatic intraocular tumors can mimic or cause uveal inflammation.

---

Symptoms

The characteristic symptoms of iridocyclitis include:

• Red eyes can result from ciliary flush, a specific pattern of redness. This involves engorgement of the conjunctival and perilimbal vessels (those around the cornea) and is especially common in anterior uveitis. Unlike conjunctivitis, which causes diffuse redness, ciliary flush appears more localized.

• Eye pain typically presents as a deep, dull, aching sensation. It may affect one or both eyes, depending on the underlying cause. Pain often worsens with light exposure (due to iris spasm) and eye movement.

• Photophobia, or hypersensitivity to light, is one of the most distressing and characteristic symptoms. Even moderate ambient light can cause significant discomfort and pain, mediated by spasm of the inflamed iris and ciliary muscle.

• Excessive tearing (epiphora): reflex lacrimation in response to pain and photophobia.

• Burning sensation.

• Visual disturbances, such as reduced visual acuity and blurred vision, occur when protein and inflammatory cells in the aqueous humor cloud the optical pathway. They can also result from associated corneal changes.

• Persistent miosis occurs when the pupil remains constricted because of irritation and spasm of the sphincter pupillae. This condition also contributes to photophobia.

• Corneal opacities, fine deposits on the inner corneal surface (also known as keratic precipitates), can affect vision.

• Blepharospasm is an involuntary, tonic spasm of the eyelids. This condition often makes it difficult to open the eye during examination.

Any patient presenting with eye pain, redness, photophobia, and reduced vision, even if mild, should be promptly evaluated by an ophthalmologist. This evaluation is necessary to rule out iridocyclitis or another form of anterior uveitis**.

---

Complications

When iridocyclitis isn’t promptly diagnosed and treated, or when it progresses to pan-uveitis (which involves the entire uveal tract), serious and potentially irreversible complications can develop.

• Glaucoma: Inflammatory debris and synechiae can obstruct the drainage of aqueous humor, causing a rise in intraocular pressure. Chronic elevated pressure damages the optic nerve and can ultimately lead to permanent blindness if untreated.

• Retinal detachment: Severe or prolonged uveitis may compromise the structural integrity of the retina. This increases the risk of detachment, which is a sight-threatening emergency.

• Extension of inflammation: The inflammatory process can spread to involve the cornea (keratitis), sclera (scleritis), vitreous humor, or retina.

• Cataract formation: Chronic inflammation, prolonged corticosteroid use, or posterior synechiae (adhesions between the iris and lens) accelerate lens opacification, leading to secondary cataract.

• Band keratopathy: Calcium deposits in the superficial cornea, associated with chronic inflammation (particularly in juvenile idiopathic arthritis-associated uveitis).

• Cystoid macular edema (CME): Fluid accumulation in the central retina, known as the macula, which causes central visual distortion and reduction. It is one of the leading causes of visual impairment in uveitis.

---

Diagnosis

Medical History (Anamnesis)

The diagnostic process begins with a thorough medical history. The physician systematically investigates:

• The onset, nature, duration, and progression of symptoms
• Prior episodes of eye inflammation
• Known autoimmune diseases, including arthritis, inflammatory bowel disease, or sarcoidosis
• Allergies
• Diabetes mellitus
• Prior ocular trauma or surgery
• Current medications (some drugs can cause uveal inflammation)
• Recent infections or travel history (relevant for infectious causes)
• Family history of uveitis or autoimmune disease

Physical Examination

A thorough ophthalmic examination is performed to document all clinical signs and to differentiate iridocyclitis from other causes of red eye. These include, in particular, conjunctivitis, retinitis pigmentosa, or severe keratitis.

Key specialized examination tools include:

Slit-Lamp Biomicroscopy

The slit lamp is the most important diagnostic instrument in uveitis. It provides magnified, high-resolution illumination of the anterior and posterior segments of the eye, allowing identification of the characteristic signs of iridocyclitis:

• Blepharospasm, often noticed even before the formal examination starts, may be present.
• Tyndall phenomenon (flare and cells): Light scattered by protein (flare) and inflammatory cells suspended in the aqueous humor. This is the hallmark sign of active anterior uveitis. Graded on a standardized scale.
• Keratic precipitates (KPs): Inflammatory cell deposits on the inner surface of the cornea. Fine, stellate KPs suggest non-granulomatous uveitis; large, “mutton-fat” KPs are characteristic of granulomatous uveitis (e.g., sarcoidosis, tuberculosis).
• Hypopyon: A visible layer of white cells settled at the bottom of the anterior chamber. This finding is seen in severe inflammation and is associated with conditions such as Behçet’s disease, HLA-B27 uveitis, and bacterial endophthalmitis.
• Iris nodules: Koeppe nodules, located at the pupillary margin, or Busacca nodules, found on the iris stroma, are hallmarks of granulomatous uveitis.
• Synechiae: Inflammatory adhesions between the iris and adjacent structures:
  • Posterior synechiae: iris adheres to the anterior lens surface, which can obstruct pupil dilation. This may cause iris bombe (pupillary block) and lead to glaucoma or cataract.
  • Anterior synechiae: iris adheres to the cornea, which can obstruct the trabecular drainage angle and cause glaucoma.

Tonometry

Measurement of intraocular pressure (IOP) is essential. Iridocyclitis can cause:

• Ocular hypotony (low IOP), caused by reduced aqueous humor production from the inflamed ciliary body.
• Elevated IOP, resulting from trabecular blockage by inflammatory cells or synechiae formation, indicates secondary glaucoma.

Ophthalmoscopy (Funduscopy)

Performed after pupillary dilation, this examination evaluates the posterior segment of the eye. It checks the vitreous, retina, optic disc, and choroid for signs of inflammation in these areas.

Laboratory and Systemic Investigations

Once iridocyclitis is confirmed, laboratory tests are directed at identifying the underlying cause:

• Complete blood count (CBC), ESR, CRP (markers of systemic inflammation)
• HLA-B27 antigen typing is positive in ankylosing spondylitis and other seronegative spondyloarthropathies.
• ANA, anti-dsDNA, RF are markers used for lupus and rheumatoid arthritis.
• ACE (angiotensin-converting enzyme) and chest X-ray or CT scans are commonly used for diagnosing sarcoidosis.
• Serological tests for syphilis (VDRL/TPHA), tuberculosis (Quantiferon-TB), herpes viruses, toxoplasmosis
• Blood glucose and HbA1c: key indicators for diagnosing and monitoring diabetes mellitus.
• Urinalysis.

An ocular biopsy (sampling uveal or vitreous tissue) is rarely necessary but may be performed in atypical or diagnostically challenging cases, with pathological analysis guiding treatment.

---

Treatment

The treatment of iridocyclitis pursues three primary objectives:

1. Relieve pain and discomfort to restore the patient’s quality of life.
2. Address the underlying cause to achieve lasting resolution.
3. Prevent and manage complications before they become severe or irreversible.

Topical and Systemic Anti-inflammatory Therapy

Corticosteroids are the mainstay of anti-inflammatory treatment:

• Topical corticosteroid eye drops (e.g., prednisolone acetate 1%, dexamethasone): used as the first-line approach in anterior uveitis. Frequency is adjusted based on disease activity. In severe acute cases, it may be as often as every hour, then tapered as inflammation resolves. Abrupt discontinuation should be avoided as it may cause rebound inflammation.
• Periocular corticosteroid injections (subconjunctival or sub-Tenon’s): used when topical drops fail or in cases with significant posterior involvement
• Systemic corticosteroids (oral prednisone): reserved for severe bilateral disease, posterior involvement, or failure of local treatment

Mydriatic (Cycloplegic) Agents

Mydriatic and cycloplegic eye drops (e.g., atropine 1%, cyclopentolate, tropicamide) are prescribed alongside anti-inflammatory therapy:

• Relieve ciliary spasm: the ciliary muscle is paralyzed, significantly reducing pain and photophobia
• Prevent posterior synechiae: pupillary dilation prevents the inflamed iris from adhering to the lens
• Break existing posterior synechiae: dilation can separate early adhesions before they become fibrous and permanent

Ocular Patching

Ocular patching of the affected eye may be useful in the most acute and painful phase, reducing light exposure and providing symptomatic relief.

Etiology-Specific Treatments

Once the underlying cause is identified, targeted therapy is added:

• Antibiotics: used for bacterial infections such as tuberculosis, syphilis, brucellosis, or leprosy. Treatment is typically systemic.
• Antiviral agents (acyclovir, valacyclovir, ganciclovir): for herpetic uveitis (HSV, VZV, CMV).
• Antifungal agents: for fungal endophthalmitis (candidiasis, histoplasmosis).
• Immunosuppressive agents: for autoimmune-related uveitis refractory to or requiring corticosteroid-sparing therapy. Options include:
  • Methotrexate.
  • Azathioprine.
  • Mycophenolate mofetil.
  • Cyclosporine.
  • Biologic agents (anti-TNF agents such as adalimumab, which is FDA/EMA approved for non-infectious uveitis): these are increasingly used in refractory cases, particularly in JIA-associated uveitis and ankylosing spondylitis.

Complications Management

• Glaucoma: managed with topical or systemic IOP-lowering agents; surgical intervention (trabeculectomy, drainage devices) may be required in refractory cases
• Cataract: surgical removal (phacoemulsification with IOL implantation) once inflammation is well controlled
• Cystoid macular edema: treated with periocular corticosteroid injections, topical NSAIDs, or anti-VEGF agents

Prognosis

• Uncomplicated acute iridocyclitis, particularly when it is infectious in origin and promptly treated, generally carries a good prognosis with full resolution.
• Chronic or recurrent iridocyclitis, particularly when linked to autoimmune conditions, tends to be more difficult to control. It often requires prolonged treatment and carries a higher risk of vision-threatening complications.
• Regular ophthalmic follow-up is essential even when the patient feels asymptomatic, as subclinical inflammation and complications (particularly in juvenile idiopathic arthritis) can progress silently

---

Sources and Bibliography

• Kanski’s Clinical Ophthalmology: A Systematic Approach. Brad Bowling, C. Azzolini, S. Donati (eds.). EDRA Edition.
• Jabs DA, et al. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American Journal of Ophthalmology. 2005;140(3):509–516.
• Dick AD, et al. Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative. Ophthalmology. 2018;125(5):757–773.
• Tsirouki T, et al. A Focus on the Epidemiology of Uveitis. Ocular Immunology and Inflammation. 2018;26(1):2–16.